Skip to main content
Retour
Watch Compare

Vicarious Surgical Inc.

Qualité des données : 83%
Également cotée sous RBOTW OTC
RBOT
OTC Manufacturing Measuring & Analyzing Instruments
0,70 €
▼ 0,07 € (-8,50%)
Cap. Boursière: 4,99 M
Prix
0,70 €
Cap. Boursière
4,99 M
Fourchette du Jour
0,70 € — 0,76 €
Fourchette 52 Semaines
0,27 € — 13,75 €
Volume
2 607
Ouverture 0,76 €
Moyenne 50J / 200J
1,45 €
51,74% below
Moyenne 50J / 200J
4,61 €
84,80% below

Quick Summary

Points Clés

Negative free cash flow of -45,21 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-270,15%
En dessous de la moyenne du secteur (-53,41%)
ROIC-127,56%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,75
Interest CoverageN/A

Valorisation

PE (TTM)
-0,10
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,35
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,1 -1,5
P/B 0,4 1,6
ROE % -270,2 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -50,18 M
ROE -270,15% ROA -142,89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -45,21 M
ROIC -127,56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,75
Interest Coverage N/A Asset Turnover N/A
Working Capital 11,90 M Tangible Book Value 14,09 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,10 Forward P/E N/A
P/B Ratio 0,35 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -906,53%
Market Cap 4,99 M Enterprise Value 1,82 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -6,35 OCF / Share -6,33
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 90,09%
SBC-Adj. FCF -55,18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — — — — —
Net Income -50,18 M -63,22 M -71,07 M 5,16 M -161 178,0
EPS (Diluted) — — -0,49 0,04 —
Gross Profit — — — — —
Operating Income -50,03 M -66,56 M -80,67 M -80,08 M —
EBITDA — — — — —
R&D Expenses 33,60 M 40,16 M 47,58 M 43,90 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — 25 000,0 25 000,0 200 000,0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 19,58 M 67,72 M 119,86 M 140,29 M 346,42 M
Total Liabilities 9,74 M 21,02 M 21,90 M 29,25 M 12,20 M
Shareholders' Equity 9,84 M 46,70 M 97,97 M 111,05 M 5,00 M
Total Debt — — 2,00 M 2,18 M —
Cash & Equivalents 2,57 M 9,74 M 52,82 M 116,21 M 1,10 M
Current Assets 11,58 M 51,70 M 100,95 M 120,40 M 1,23 M
Current Liabilities 3,90 M 7,67 M 7,28 M 8,39 M 126 220,0